(1S)-1-[(2S,3S,4S,5S,6S)-6-[[(2R,3R,4R,5S,6R,7R,9S)-3,7-dimethoxy-2-[(2R,5S)-5-[(2R,5R)-5-[(2S,3S,4S,5R,6S)-6-methoxy-4-[(2R,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxy-3,5,6-trimethyloxan-2-yl]oxolan-2-yl]oxolan-2-yl]-2,4,6-trimethyl-1,10-dioxaspiro[4.5]decan-9-yl]methyl]-2-hydroxy-4,5-dimethoxy-3,5-dimethyloxan-2-yl]-1-hydroxypropan-2-one

Term ID

CHEBI:210635

Synonyms

(1S)-1-[(2S,3S,4S,5S,6S)-6-[[(2R,3R,4R,5S,6R,7R,9S)-3,7-dimethoxy-2-[(2R,5S)-5-[(2R,5R)-5-[(2S,3S,4S,5R,6S)-6-methoxy-4-[(2R,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxy-3,5,6-trimethyloxan-2-yl]oxolan-2-yl]oxolan-2-yl]-2,4,6-trimethyl-1,10-dioxaspiro[4.5]decan

Definition

References

Chemspider:80564744

Ontology

ChEBI ( EBI )

Relationships

is a type of: C-glycosyl compound

C-glycosyl compound Show first 5 Terms

Phenotype

Phenotype resulting from (1S)-1-[(2S,3S,4S,5S,6S)-6-[[(2R,3R,4R,5S,6R,7R,9S)-3,7-dimethoxy-2-[(2R,5S)-5-[(2R,5R)-5-[(2S,3S,4S,5R,6S)-6-methoxy-4-[(2R,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxy-3,5,6-trimethyloxan-2-yl]oxolan-2-yl]oxolan-2-yl]-2,4,6-trimethyl-1,10-dioxaspiro[4.5]decan-9-yl]methyl]-2-hydroxy-4,5-dimethoxy-3,5-dimethyloxan-2-yl]-1-hydroxypropan-2-one

Phenotype where environments contain (1S)-1-[(2S,3S,4S,5S,6S)-6-[[(2R,3R,4R,5S,6R,7R,9S)-3,7-dimethoxy-2-[(2R,5S)-5-[(2R,5R)-5-[(2S,3S,4S,5R,6S)-6-methoxy-4-[(2R,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxy-3,5,6-trimethyloxan-2-yl]oxolan-2-yl]oxolan-2-yl]-2,4,6-trimethyl-1,10-dioxaspiro[4.5]decan-9-yl]methyl]-2-hydroxy-4,5-dimethoxy-3,5-dimethyloxan-2-yl]-1-hydroxypropan-2-one

Phenotype modified by environments containing (1S)-1-[(2S,3S,4S,5S,6S)-6-[[(2R,3R,4R,5S,6R,7R,9S)-3,7-dimethoxy-2-[(2R,5S)-5-[(2R,5R)-5-[(2S,3S,4S,5R,6S)-6-methoxy-4-[(2R,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxy-3,5,6-trimethyloxan-2-yl]oxolan-2-yl]oxolan-2-yl]-2,4,6-trimethyl-1,10-dioxaspiro[4.5]decan-9-yl]methyl]-2-hydroxy-4,5-dimethoxy-3,5-dimethyloxan-2-yl]-1-hydroxypropan-2-one

Human Disease Model